ER+/HER2+ Metastatic Breast Cancer

1 意见
administrator
administrator
07/03/23

Hope S. Rugo, MD, looks at the use of CDK4/6 inhibitors for patients with metastatic ER-positive, HER2-positive breast cancer and the trials evaluating their use in this setting.

  • 类别

显示更多

0 注释 排序方式

没有找到评论

脸书评论

下一个